| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Complex carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Refined carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate derivative (substance) |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Gamma-ketovaleric acid (substance) |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Pectin |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Polysaccharide |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Simple carbohydrate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Saccharidmåling |
Has measured component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Malabsorption due to intolerance to carbohydrate |
Causative agent |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate identification |
Has measured component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Saccharidmåling |
Component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate identification |
Component |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Metabolic acidosis due to grain overload (disorder) |
Causative agent |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Product containing glucose (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Glucose 400 mg/g oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,225 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 10 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 %/glucose 2,5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,45 % + glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumklorid 0,9 %/glucose 5 % infusionsvæske opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing carbohydrate (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Product containing glucose and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 60g injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 25 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose 5g/100mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 % injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| 60 minute plasma xylose level (procedure) |
Component |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrosepræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Kulhydrattilskud |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Tilskud bestående af sammensatte kulhydrater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| tilskud bestående af raffinerede kulhydrater |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| cholestyramin + aspartam 4g/brev pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| stilbestrol 500 µg + mælkesyre 5 % vagitorium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Intravenous nutrition (carbohydrate) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing aspartame (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing diethylstilbestrol and lactic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 % i 0,2 % normalt saltvand |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kolestyramin + aspartam |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 5 % infusionsvæske, opløsning, pose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske opløsning, hætteglas a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 1000 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) infusionsvæske opløsning, hætteglas a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 25 % injektionsvæske til spædbørn, opløsning, hætteglas a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 60 % i vand, infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) iinjektionsvæske, opløsning, sprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 150 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 25 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 100 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| dekstrose 5 g/100 ml (5 %) injektionsvæske, opløsning, flaske a 250 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 5 g/100 ml (5 %) injektionsvæske, opløsning, hætteglas a 50 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactic acid 50 mg/g and urea 100 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| salicylsyre + mælkesyre 16,7 %/16,7 % præparat til pensling |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,18 %/glucose 4 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| natriumchlorid 0,9 %/glucose 5 % infusionsvæske, opløsning, polyætylenflaske a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing acesulfame potassium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 10 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 20 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 30 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 40 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Glucose 500 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 60 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| glucose 70 % opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| alkohol + dekstsrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| theophyllin + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Ringer-laktat, opløsning + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Ringer-laktat, opløsning med 2,5 % glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Ringers opløsning med lactat + 5 % glucose + 0,15 % kaliumhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| milrinon + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| morphinsulfat + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Bupivacaine + dextrose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| cefoxitin + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| cholestyramin + aspartam 4 g/brev sukkerfrit oralt pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| bupivacainhydrochlorid 7,5 mg/glucose 82,5 mg injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar phosphate |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar alcohol |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 10 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 10 mmol/glucose 5 %/natriumchlorid 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 13,5 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 20 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 27 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 40 mmol/glucose 4 %/natriumchlorid 0,18 % infusionsvæske, opløsning, pose a 1 l |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kalium + glucose infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kalium + glucose/saltvand infusionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| kaliumchlorid 10 %/natriumchloridd 0,45 % infusionsvæske, opløsning, pose a 500 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Product containing glucose and potassium chloride and sodium chloride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Dextrose + potassium chloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate food |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Sugar acid (substance) |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
| Intravenous nutrition (carbohydrate) adverse reaction |
Causative agent |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Oligosaccharide |
Is a |
False |
Carbohydrate |
Inferred relationship |
Some |
|
| Carbohydrate measurement |
Component |
True |
Carbohydrate |
Inferred relationship |
Some |
1 |
| Wheat dextrin |
Is a |
True |
Carbohydrate |
Inferred relationship |
Some |
|
FHIR